SR

SRX HealthSolutions Inc

SRXH
Accountable AI Logo

SRX HealthSolutions Inc AI Insights

Informational only. Not investment advice.
As of 2025-12-17

Snapshot

  • Debt-to-equity of 11.0x with only 1.3M cash vs 4.5M total debt TTM - equity cushion nearly exhausted at 407K book value[Debt to Equity]
  • FCF of -8.1M TTM exceeds entire market cap of 9.9M - burning through more than company's worth annually[Free Cash Flow TTM]
  • Operating margin -175% TTM vs industry median +2% - spending 12.9M to generate 6.5M revenue[Operating Margin TTM]

Watch Triggers

  • Cash and Equivalents TTM: Falls below 500K or new financing announcedAt current burn, insolvency risk within Q1 2026 without capital raise
  • Operating Margin TTM: Improves to -100% or betterWould signal path to breakeven; currently -175% is terminal trajectory
  • Shares Outstanding: Increases >50% from 26.4MMassive dilution likely; current shareholders face significant equity erosion

Bull Case

Gross margin 23% TTM shows viable unit economics if scale achieved - below industry median 44% but positive

Gross Margin TTMGross Profit TTM

Working capital 4.6M with 3.9M receivables suggests revenue pipeline; asset turnover 0.78x near industry median 0.79x

Working Capital TTMAsset Turnover TTM

Bear Case

ROE -11,058% and ROIC -922% TTM indicate catastrophic capital destruction - every dollar invested loses 9 cents annually

ROE TTMROIC TTM

P/B 24x for company with negative earnings and cash runway under 2 months - valuation assumes turnaround not in evidence

P/B Ratio TTMCash and Equivalents TTM

Bull vs Bear Balance

AI-generated sentiment analysis based on fundamental metrics and market conditions.

BearBull
15%

Leverage SRXH's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.

Take Me to The Editor

Forward Thesis

Capital structure unsustainable without dilutive financing within 6 months

3-12mhigh
  • Cash of 1.3M vs monthly burn rate ~680K
  • Debt/equity at 11x limits borrowing capacity
  • 9.2M stock issuance already consumed
FCF -8.1M TTM, cash 1.3MLong-term debt 4.5M vs equity 407KIssuance of capital stock -9.2M TTM

Valuation Context

Caveats

Public Strategies Rankings

See how SRX HealthSolutions Inc ranks across different investment strategies.

Leverage SRXH's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.

Data Partners
Morningstar Logo

Fundamental company data provided by Morningstar, updated daily.

Accountable Finance, Inc. Disclaimer
accountable.finance is not operated by a broker or a dealer. Under no circumstances does any information posted on accountable.finance represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. In no event shall accountable.finance be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on accountable.finance, or relating to the use of, or inability to use, accountable.finance or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. Stock quotes and fundamental company data provided by Morningstar, updated daily.

Accountable Logo
© 2026 Accountable Finance, Inc. All rights reserved.